HealthStream Inc (HSTM) stock
HSTMNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/3013% below fair value
$27.63−0.05 (-0.18%)
Close on Nov 17, 2026Market cap $807.90MP/E 38.4Yield 0.45%
HealthStream EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
HealthStream's EPS for the twelve months ending Jun 30, 2026 was $0.72, up 7.5% year over year. For fiscal 2025 it was $0.61, down 7.6% from the year before. Over ten years it grew 8.1% a year on average. The highest annual figure on record is $1.00 in fiscal 2018.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $0.61 | -7.6% |
| FY2024 | Dec 31, 2024 | $0.66 | +32.0% |
| FY2023 | Dec 31, 2023 | $0.50 | +28.2% |
| FY2022 | Dec 31, 2022 | $0.39 | +116.7% |
| FY2021 | Dec 31, 2021 | $0.18 | -59.1% |
| FY2020 | Dec 31, 2020 | $0.44 | -10.2% |
| FY2019 | Dec 31, 2019 | $0.49 | -51.0% |
| FY2018 | Dec 31, 2018 | $1.00 | +222.6% |
| FY2017 | Dec 31, 2017 | $0.31 | +158.3% |
| FY2016 | Dec 31, 2016 | $0.12 | -57.1% |
| FY2015 | Dec 31, 2015 | $0.28 | -24.3% |
| FY2014 | Dec 31, 2014 | $0.37 | +23.3% |
| FY2013 | Dec 31, 2013 | $0.30 | +7.1% |
| FY2012 | Dec 31, 2012 | $0.28 | -3.4% |
| FY2011 | Dec 31, 2011 | $0.29 | +61.1% |
| FY2010 | Dec 31, 2010 | $0.18 | -71.9% |
| FY2009 | Dec 31, 2009 | $0.64 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $0.23 | +27.8% |
| Q1 FY2026 | Mar 31, 2026 | $0.20 | +42.9% |
| Q4 FY2025 | Dec 31, 2025 | $0.09 | -43.8% |
| Q3 FY2025 | Sep 30, 2025 | $0.20 | +5.3% |
| Q2 FY2025 | Jun 30, 2025 | $0.18 | +28.6% |
| Q1 FY2025 | Mar 31, 2025 | $0.14 | -17.6% |
| Q4 FY2024 | Dec 31, 2024 | $0.16 | +6.7% |
| Q3 FY2024 | Sep 30, 2024 | $0.19 | +46.2% |
| Q2 FY2024 | Jun 30, 2024 | $0.14 | +7.7% |
| Q1 FY2024 | Mar 31, 2024 | $0.17 | +88.9% |
| Q4 FY2023 | Dec 31, 2023 | $0.15 | +87.5% |
| Q3 FY2023 | Sep 30, 2023 | $0.13 | +8.3% |
| Q2 FY2023 | Jun 30, 2023 | $0.13 | +30.0% |
| Q1 FY2023 | Mar 31, 2023 | $0.09 | 0.0% |
| Q4 FY2022 | Dec 31, 2022 | $0.08 | – |
| Q3 FY2022 | Sep 30, 2022 | $0.12 | +140.0% |
| Q2 FY2022 | Jun 30, 2022 | $0.10 | +25.0% |
| Q1 FY2022 | Mar 31, 2022 | $0.09 | +28.6% |
| Q4 FY2021 | Dec 31, 2021 | -$0.01 | -133.3% |
| Q3 FY2021 | Sep 30, 2021 | $0.05 | -37.5% |
| Q2 FY2021 | Jun 30, 2021 | $0.08 | -27.3% |
| Q1 FY2021 | Mar 31, 2021 | $0.07 | -68.2% |
| Q4 FY2020 | Dec 31, 2020 | $0.03 | -72.7% |
| Q3 FY2020 | Sep 30, 2020 | $0.08 | -27.3% |
| Q2 FY2020 | Jun 30, 2020 | $0.11 | +57.1% |
| Q1 FY2020 | Mar 31, 2020 | $0.22 | +22.2% |
| Q4 FY2019 | Dec 31, 2019 | $0.11 | +22.2% |
| Q3 FY2019 | Sep 30, 2019 | $0.11 | +22.2% |
| Q2 FY2019 | Jun 30, 2019 | $0.07 | -12.5% |
| Q1 FY2019 | Mar 31, 2019 | $0.18 | -75.7% |
| Q4 FY2018 | Dec 31, 2018 | $0.09 | -25.0% |
| Q3 FY2018 | Sep 30, 2018 | $0.09 | +12.5% |
| Q2 FY2018 | Jun 30, 2018 | $0.08 | +14.3% |
| Q1 FY2018 | Mar 31, 2018 | $0.74 | +1750.0% |
| Q4 FY2017 | Dec 31, 2017 | $0.12 | – |
| Q3 FY2017 | Sep 30, 2017 | $0.08 | +100.0% |
| Q2 FY2017 | Jun 30, 2017 | $0.07 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.04 | – |
| Q4 FY2016 | Dec 31, 2016 | -$0.01 | – |
| Q3 FY2016 | Sep 30, 2016 | $0.04 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?